Gerhard Krauss Biochemistry of Signal Transduction and Regulation(3rd Edition) ISBN: 3-527-30591-2 LOGO Intracellular Messenger Substances: “Second Messengers” 授課老師: 褚俊傑副教授 (生物科技系暨研究所) 聯絡電話: 0986-581835 電子信箱: jjchuu@mail.stut.edu.tw Second Messengers inside the cell Many different kinds of molecules can serve as second messengers. The signal, or ligand, binding to a membrane receptor leads to the production of second messengers inside the cell. The original signal usually doesn't enter the cell. The small molecule "cAMP" was the initial second messenger to be identified. Other examples of second messengers include NO, IP3, and DAG. The figure below shows an example of the production of second messengers. Outline 6.1 General Functions of Intracellular Messenger Substances 6.2 cAMP 6.3 cGMP 6.4 Metabolism of Inositol Phospholipids and Inositol Phosphates 6.5 Inositol 1,4,5-Triphosphate and Release of Ca2+ 6.6 Phosphatidyl Inositol Phosphates and PI3Kinase 6.7 Ca2+ as a Signal Molecule 6.8 Diacylglycerol as a Signal Molecule 6.9 Other Lipid Messengers 6.1 General Functions of Intracellular Messenger Substances Extracellular signals are registered by membrane receptors and conducted into the cell via cascades of coupled reactions. The first steps of signal transmission often take place in close association with the membrane, before the signal is conducted into the cell interior. The cell uses mainly two mechanisms for transmission of signals at the cytosolic side of the membrane and in the cell interior. Signal transmission may be mediated by a protein-protein interaction. The proteins involved may be receptors, proteins with adaptor function alone, or enzymes. Signals may also be transmitted with the help of low-molecular-weight messenger substances. These are known as “second messengers”. The intracellular messenger substances are formed or released by specific enzyme reactions during the process of signal transduction, and serve as effectors, with which the activity of proteins further in the sequence is regulated (Fig. 6.1). Fig. 6.1 Function and formation of intracellular messenger substances in signaling pathways. Starting from the activated receptor, effector proteins next in sequence are activated that create an intracellular signal in the form of diffusible messenger substances. The hydrophilic messenger substances diffuse to target proteins in the cytosol and activate these for signal transmission further. Hydrophobic messenger substances, in contrast, remain in the cell membrane and diffuse at the level of the cell membrane to membrane-localized target proteins. PK: protein kinase; S: substrate of the protein kinase. 6.1 General Functions of Intracellular Messenger Substances The most important “second messengers” are – hydrophilic, cytosolic: cAMP, cGMP inositol phosphates Ca2+ – hydrophobic, membrane-associated: diacylglycerol phosphatidyl inositol phosphates. 6.2 cAMP 3’-5’-cyclic AMP is a central intracellular “second messenger” that influences many cellular functions, such as gluconeogenesis, glycolysis, lipogenesis, muscle contraction, membrane secretion, learning processes, ion transport, differentiation, growth control and apoptosis. 6.2 cAMP cAMP-gated Ion Channels An important function of cAMP is the regulation of ion passage through cAMP-gated ion channels. cAMP binds to cytoplasmic structural elements of these ion channels and regulates their open state. An example is the cAMP-regulated Ca2+ passage through cation channels. cAMP also performs this function during the perception of smell in mammals. 6.2 cAMP Protein Kinase A The majority of the biological effects of cAMP are mediated by the activation of protein kinases. Protein kinases regulated by cAMP are classified as protein kinase A. The mechanism of activation of protein kinases of type A by cAMP is schematically represented in Fig. 6.2. In the absence of cAMP, protein kinase A exists as a tetramer, composed of two regulatory (R) and two catalytic (C) subunits. In the tetrameric R2C2 form, protein kinase A is inactive since the catalytic center of the C subunit is blocked by the R subunit. Fig. 6.2 Regulation of protein kinase A via cAMP. Protein kinase A is a tetrameric enyzme composed of two catalytic subunits (C) and two regulatory subunits (R). In the R2C2 form, protein kinase A is inactive. Binding of cAMP to R leads to dissociation of the tetrameric enyzme into the R2 form with bound cAMP and free C subunits. In the free form, C is active and catalyzes the phosphorylation of substrate proteins (S) at Ser/Thr residues. 6.3 cGMP Like cAMP, 3’-5’-cGMP is widespread as an intracellular messenger substance. Analogous to cAMP, cGMP is formed by catalysis via guanylyl cyclase from GTP. Although the guanylyl cyclases catalyze a similar reaction as the adenylyl cyclases, the two enzyme classes differ considerably in structure and mechanism of activation. The guanylyl cyclases can be divided into three groups according to the number of transmembrane segments. One group contains enzymes that do not contain a transmembrane segment and are referred to as soluble guanylyl cyclases. A second group contains one transmembrane segment. The members of this group are directly regulated by extracellular ligands and therefore have receptor function. A third group with more than two transmembrane segments is only poorly characterized, and its ligands or mechanism of activation is not yet known. 6.3 cGMP Guanylyl Cyclases with a Single Transmembrane Segment The guanylyl cyclases with a single transmembrane segment function as receptors that contain an extracellular ligandbinding domain and various intracellular domains that are required for the ligand-regulated activation of the enzyme (Fig. 6.3) . As ligands for the guanylyl cyclase receptors, peptides with vasodilatory properties like the atrial natriuretic peptide have been identified. The receptor-type guanylyl cyclases are therefore also termed natriuretic peptide receptors, NPR. The receptors exist in a homodimeric transmembrane form, and its intracellular guanylyl cyclase domain is activated by peptide binding to the extracellular domains. A complicated series of reactions follow activation, which include phosphorylation of an intracellular kinase-homology domain, ATP binding and finally activation of cGMP synthesis. Fig. 6.3 Model of the domain structure of the natriuretic peptide receptor NPR, a receptor type guanylyl cyclase. NPR is a dimeric transmembrane receptor which spans the membrane with two transmembrane elements. The extracytosolic domain comprises the ligand binding site and contains several disulfide bridges. The cytosolic part is composed of a kinase homology domain with multiple phosphorylation sites, an ATP binding site of unknown function and the catalytic guanylyl cyclase domain. 6.3 cGMP Soluble Guanylyl Cyclases The soluble guanylyl cyclases exist as heterodimers and are regulated by the second messenger NO. A heme group that confers NO-sensitivity is bound at the Nterminus of these enzymes. NO binding to the heme group results in activation of the guanylyl cyclase activity. The second messenger function of cGMP is directed towards three targets: * cGMP-dependent protein kinases * Cation channels * cAMP-specific phosphodiesterases 6.4 Metabolism of Inositol Phospholipids and Inositol Phosphates Inositol-containing phospholipids of the plasma membrane are the starting compounds for the formation of various lowmolecular-weight inositol messengers in response to various intra-and extracellular signals. These messengers include the central second messengers diacylglycerol and inositol trisphosphate as well as membrane bound phosphatidyl inositol phosphates. The plasma membrane contains the phospholipid phosphatidyl inositol (PtdIns), in which the phosphate group is esterified with a cyclic alcohol, myo-D-inositol (Fig. 6.4). Starting from PtdIns, a series of enzymatic transformations lead to the generation of a diverse number of second messengers. PtdIns is first phosphorylated by specific kinases at the 4’ and 5’ positions of the inositol residue, leading to the formation of phosphatidyl inositol-4,5-bisphosphate [PtdIns(4,5)P2]. Fig. 6.4 Formation of diacylglycerol, Ins(1,4,5)P3 and PtdIns(3,4,5)P3. PL-C: phospholipase of type C: PI3kinase: phosphatidyl inositol-3’kinase. 6.4 Metabolism of Inositol Phospholipids and Inositol Phosphates Inositol Phosphates and Regulation of Phospholipase C Phospholipase C, which occurs in different subtypes in the cell, is a key enzyme of phosphatide inositol metabolism. Two central signaling pathways regulate phospholipase C activity of the cell in a positive way (Fig. 6.5). Phospholipases of type Cβ (PL-Cβ) are activated by G proteins and are thus linked into signal paths starting from G protein-coupled receptors. Phospholipases of type γ (PL-Cγ), in contrast, are activated by transmembrane receptors with intrinsic or associated tyrosine kinase activity. Fig. 6.5 Formation and function of diacylglycerol and Ins(1,4,5)P3. Formation of diacylglycerol (DAG) and Ins(1,4,5)P3 is subject to regulation by two central signaling pathways, which start from transmembrane receptors with intrinsic or associated tyrosine kinase activity or from G-proteincoupled receptors. DAG activates protein kinase C (PKC), which has a regulatory effect on cell proliferation, via phosphorylation of substrate proteins. Ins(1,4,5)P3 binds to corresponding receptors (InsP3-R) and induces release of Ca2+ from internal stores. The membrane association of DAG, PtdIns(3,4)P2 and PL-C is not shown here, for clarity. 6.4 Metabolism of Inositol Phospholipids and Inositol Phosphates Metabolic Cycle of Inositol Phosphate The inositol phosphates are linked into a metabolic cycle (Fig. 6.6) in which they can be degraded and regenerated. Via these pathways, the cell has the ability to replenish stores of inositol phosphate derivatives, according to demand. PtdIns may be regenerated from diacylglycerol via the intermediate levels of phosphatidic acid and CDP-glycerol. Regeneration of PtdIns in the inositol cycle is of particular importance in the vision process in Drosophil. In Drosophila, InsP3 serves as a messenger during perception of light. On incidence of light, InsP3 is formed from PtdInsP2. It has been shown that CDP diacylglycerol synthase, which supplies CDP diacylglycerol for the resynthesis of PtIns (see Fig. 6.6) has an essential role in light perception in Drosophila Fig. 6.6 Metabolic cycle of regeneration of PtdIns(4,5)P2 6.5 Inositol 1,4,5-Triphosphate and Release of Ca2+ 6.5.1 Release of Ca2+ from Ca2+ Storage 6.5.2 Influx of Ca2+ from the Extracellular Region 6.5.3 Removal and Storage of Ca2+ 6.5.4 Temporal and Spatial Changes in Ca2+ Concentration 6.5 Inositol 1,4,5-Triphosphate and Release of Ca2+ The primary signal function of Ins(1,4,5)P3 is the mobilization of Ca2+ from storage organelles. Ca2+ is a ubiquitous signaling molecule whose signaling function is activated by its release from intracellular stores or through Ca2+ -entry channels from the extracellular side. A multitude of second messengers has been shown to induce an increase of intracellular Ca2+. The free Ca2+ concentration is subject to strict regulation, and targeted increase of Ca2+ is a universal means of controlling a vast array of metabolic and physiological reactions. Many processes are involved in Ca2+ regulation (Fig. 6.7), allowing the cell to shape Ca2+ signals in the dimensions of space, time and amplitude. Fig. 6.7 gives an overview of the main pathways leading to an increase or decrease of intracellular calcium. Fig. 6.7 Paths for increase and reduction of cytosolic Ca2+ concentration. Influx of Ca2+ from the extracellular space takes place via Ca2+ channels; the open state of these is controlled by binding of ligand L or by a change in the membrane potential (V). According to the type of ion channel, the ligand may bind from the cytosolic or the extracellular side to the ion channel protein. The entering Ca2+ binds to InsP3 receptors on the membrane of Ca2+ storage organelles and induces, together with InsP3, their opening. Ca2+ flows out of the storage organelle into the cytosol via the ion channel of the InsP3 receptor. Transport of Ca2+ back into the storage organelles takes place with the help of ATP-dependent Ca2+ transporters. 6.5.1 Release of Ca2+ from Ca2+ Storage Mobilization of Ca2+ from the Ca2+ stores of the endoplasmic reticulum takes place with the help of Ca2+ channels, of which two types stand out: the InsP3 receptors and the ryanodin receptors. Both are ligandgated Ca2+ channels, in which receptor and ion channel form a structural unit. The InsP3 receptors and ryanodin receptors are localized in the endoplasmic and sarcoplasmic reticulum, respectively, and may be opened during the process of signal transduction (Fig. 6.8). Fig. 6.8 Tetrameric Ca2+ channels and control of Ca2+ release. a) A change in the membrane potential (V) induces a conformational change in the dihydropyridine receptor of skeletal muscle; this is transmitted as a signal to the structurally coupled ryanodin receptor. Opening of the Ca2+ channel takes place and efflux of Ca2+ from the sarcoplasmic reticulum into the cytosol occurs. b) In cardiac muscle, the release of Ca2+ takes place by a Ca2+ -induced mechanism. A potential change V induces opening of voltage-gated Ca2+ channels. Ca2+ passes through, which serves as the trigger for release of Ca2+ from Ca2+ storage organelles by binding to ryanodin receptors on the surface of the storage organelles. c) Membraneassociated signaling pathways are activated by ligands and lead, via activated receptor and phospholipase C (PL-C) to formation of InsP3 and to release of Ca2+ from storage organelles. 6.5.1 Release of Ca2+ from Ca2+ Storage The InsP3 Receptor Binding of InsP3 to the InsP3 receptor leads to opening of the receptor channel, so that stored Ca2+ can flow into the cytosol. The InsP3 receptor is a transmembrane protein, probably with two transmembrane domains in the vicinity of the C terminus. The active receptor is composed of four identical subunits. It is assumed that the Ca2+ channel is formed by the C-terminal transmembrane element and that the binding site for InsP3 is localized in the large cytoplasmic region of the receptor. Opening of the InsP3 receptor is subject to complex regulation involving Ca2+, Mg2+ and ATP, in addition to InsP3. 6.5.1 Release of Ca2+ from Ca2+ Storage Ryanodin Receptor and Cyclic ADP Ribose The ryanodin receptor takes its name from its stimulation by the plant alkaloid ryanodin. In all, it has a similar composition to the InsP3 receptor and is involved in Ca2+ signal conduction in many excitatory cells. In some cell types (including cardiac muscle cells and pancreatic cells), another “second messenger”, the cyclic ADPribose (Fig. 6.9), is involved in opening the ryanodin receptors . The cADP-ribose is formed from NADP by an enzymatic pathway with the help of an ADP-ribosyl cyclase. Fig. 6.9 Reactions of ADP ribosyl cyclase. Structures of NADP, nicotinic acid adenine dinucleotide phosphate (NAADP) and cyclic ADP-ribose phosphate (cADPRP). ADP-ribosyl cyclase, in base exchange mode, can catalyze replacement of the nicotinamide group of NADP (yellow) with nicotinic acid to generate NAADP. ADP-ribosyl cyclase can also catalyze cyclization of NADP to cADPRP. 6.5.1 Release of Ca2+ from Ca2+ Storage Tool Kit for Ca2+ Release Overall, multiple pathways can be used for mobilising Ca2+ from the internal stores. A Ca2+ signaling ‘toolkit’ is available from which cells can select specific components to activate the internal Ca2+ stores and to generate a variety of different Ca2+ signals that suit their physiology. In summary, the following pathways can induce Ca2+ release from internal stores (Fig 6.10): * Ca2+-induced Ca2+ release from ryanodine receptors caused by influx of Ca2+ through voltage-operated Ca2+ channels on the plasma membrane. * Cyclic ADP-ribose-evoked Ca2+ release. * NAADP-evoked Ca2+ release * InsP3-evoked Ca2+ release. * Ca2+ release by interaction of InsP3 receptors with calcium binding proteins * Ca2+ release triggered by sphingolipids or leukotriene B4 2+ Fig. 6.10 Tools for Ca2+ release. The figure illustrates the major pathways for mobilising Ca2+ from internal stores. 1, Ca2+ induced Ca2+ release from ryanodine receptors (RyR) caused by the influx of Ca2+ through voltage- or ligand-gated channels on the outer cell membrane. This release may be also triggered by direct interaction of the channel with RYR. 2, PLC/InsP3 evoked release of Ca2+ from InsP3 receptors or ryanodine receptors. 3, cyclic ADP-ribose (cADPR)- evoked Ca2+ release. 4, nicotinic acid adenine dinucleotide phosphate (NAADP) evoked Ca2+ release. 5, Ca2+ release evoked by sphingosine. 6, Ca2+ release from mitochondria. 6.5.2 Influx of Ca2+ from the Extracellular Region The main Ca2+ influx channels are * Voltage-gated channels are opened by a depolarization or change in membrane potential. * Ligand-gated channels are activated by binding of an agonist to the exctracellular domain of the channel. Examples are provided by the acetylcholine receptor and the N-methylD-asparate receptor. * Mechanically activated channels are present on many cell types and respond to mechanical stress. In addition we know of Ca2+ channels that are controlled by Ga proteins and Ca2+ channels that are gated by sphingolipids. 6.5.3 Removal and Storage of Ca2+ The cytosolic Ca2+ concentration is generally only temporarily and is often only locally increased during stimulation of cells. The cell possesses efficient Ca2+ transport systems, which can rapidly transport Ca2+ back into the extracellular region or into the storage organelles. Ca2+-ATPases, in particular, are involved in draining the cytosol of Ca2+ back into the extracellular region. The Ca2+-ATPases perform active transport of Ca2+ against its concentration gradient, using the hydrolysis of ATP as an energy source. Other transport systems in the plasma membrane exchange Na+ ions for Ca2+. These Na+-Ca2+ exchange proteins are located especially in muscle cells and in neurons. Ca2+-ATPases, which can fill the empty Ca2+ storage, are also located in the membrane of the endoplasmic reticulum. 6.6 Phosphatidyl Inositol Phosphates and PI3Kinase 6.6.1 PI3-Kinases 6.6.2 The Messenger Substance PtdIns(3,4,5)P3 6.6.3 Akt Kinase and PtdIns(3,4,5)P3 Signaling 6.6.4 Functions of PtIns(4,5)P3 6.6 Phosphatidyl Inositol Phosphates and PI3Kinase Several metabolic pathways lead from phosphatidyl inositol to compounds with “second messenger” character. One main pathway, the formation of diacylglycerol and Ins(1,4,5)P3 from PtdIns(4,5)P2, has already been described in Section 6.4 and Fig. 6.4. Other major compounds of regulatory importance can be formed by phosphorylation at the 3’ position of the inositol part of PtdIns. The reaction is catalyzed by a class of enzymes known as phosphatidyl inositide 3-kinases (PI3-kinases). The PI3kinases phosphorylate various phosphatidyl inositol compounds at the 3’ position. A major substrate is PtdIns(4,5)P2, which is converted by PI3-kinase into PtdIns(3,4,5)P3. This compound has an important function as an intracellular messenger. PtdIns(3,4,5)P3 binds to PH domains of various signaling proteins promoting their membrane association. An overview of the function and regulation of PI3-kinase. is given in Fig. 6.11. Fig. 6.11 Pathways of PI3-kinase activation. PI3-kinase can be activated by growth factor receptors, either by direct interaction or via the Ras protein. Another way of PI3kinase activation uses the bcsubunits of heterotrimeric G proteins liberated upon activation of G proteincoupled receptors, GPCR. The product of the PI3-kinase reaction is PtdIns(3,4,5)P3 which binds to PH domains of various signaling proteins promoting their membrane association and activation. Overall, activation of PI3-kinase stimulates cell growth and proliferation and inhibits apoptosis. A suppressing effect is exerted by the tumor suppressor PTEN which hydrolyzes and thus inactivates PtdIns(3,4,5)P3. 6.6.1 PI3-Kinases Many observations indicate that PI3-kinase functions as a signal protein that receives signals on the cytoplasmic side of the cell membrane and transmits them further, although its primary role is to produce membranelocalized messenger substances. PI3-kinase is activated via three pathways (see Fig. 6.11). 6.6.1 PI3-Kinases Interaction with activated receptor tyrosine kinases The SH2 domain of the p85 subunit mediates an interaction with tyrosine residues on signal proteins involved in transduction of growth-regulating signals. Thus, binding of the PI3-kinase to tyrosine phosphate residues of the activated PDGF receptor is observed. Another binding partner is the insulin receptor substrate (IRS). In both cases, it is assumed that the binding of the SH2 domain of p85 to the tyrosine residue of the signal protein serves to target the PI3-kinase to its membranelocalized substrate. Furthermore, binding of p85 to phosphotyrosine residues of activated receptors appears to be accompanied by an allosteric activation of the catalytic subunit (Fig. 6.12). Fig. 6.12 (A) Activation of PKB (also known as Akt kinase) by membrane translocation. PtdIns(3,4,5)P3 generated in response to growth factor stimulation serves as a binding site for the PH domains of PDK1 and PKB. Membrane translocation is accompanied by release of an autoinhibition leading to activation of PDK1 and PKB kinase activities. Full activation of PKB requires phosphorylation by PDK1. Activated PKB phosphorylates a variety of target proteins that prevent apoptotic death (Bad) and regulate transcription (forkhead transcription factors, FKHR1) and other metabolic processes. (B) Activation by a conformational change. Binding of the SH2 domains of p85, the regulatory subunit of PI-3 kinase to pTyr sites on activated receptors releases an autoinhibitory constraint that stimulates the catalytic domain (p110). PI-3 kinase catalyzes the phosphorylation of the 3’ positions of the inositol ring of PtdIns(4)P and PtdIns(4,5)P2 to generate PtdIns(3,4)P2 and PtdIns(3,4,5)P3, respectively. 6.6.1 PI3-Kinases Activation in the Ras pathway The PI3-kinase has also been identified as a part of the Ras signaling pathway. Signals originating from transmembrane receptors can be transmitted from the Ras protein to PI3kinase. In this case, the PI3-kinase acts as the effector molecule of the Ras protein. Activation by the Gβγ dimer Gβγ dimers directly activate the PI3-kinase β and γ subtypes. In this way, a variety of extracellular signals can be transmitted via G protein-coupled receptors and G proteins to PI3-kinase and its effectors. 6.6.2 The Messenger Substance PtdIns(3,4,5)P3 The products of the PI3-kinase reaction are different phosphoinositide derivatives phosphorylated at the 3 position, of which PtdIns(3,4,5)P3 has the greatest regulatory importance. PtIns(3,4,5)P3, like cAMP, has the function of a messenger substance that activates effector molecules in the sequence for further signal conduction. The concentration of PtdIns(3,4,5)P3 in the cell depends both on the rates of synthesis by PI3-kinases and the rates of hydrolysis of its phosphate residues. Several inositol polyphosphate phosphatases have been identified that remove the phosphates at position 3 or 5 of the inositol moiety. 6.6.3 Akt Kinase and PtdIns(3,4,5)P3 Signaling PtdIns(3,4,5)P3 formed by PI3-kinase regulates the activity of a series of protein kinases, including the Ser/Thr-specific Akt kinases, protein kinase C enzymes, and the tyrosine-specific Tec kinases. Only the regulation of Akt kinase will be discussed in the following. The first target protein of PtdIns(3,4,5)P3 to be characterized was Akt kinase, also known as protein kinase B (PKB). Akt kinase is a Ser/Thr-specfic protein kinase which regulates multiple biological processes including glucose metabolism, apoptosis, gene expression, and cellular proliferation. The signaling pathway for Akt kinase shown in Fig. 6.12 illustrates the central role of PI3-kinase and PtdIns(3,4,5)P3 in growth factor controlled signal paths that lead from the cell membrane into the cytosol and the nucleus. 6.7 Ca2+ as a Signal Molecule 6.7.1 Calmodulin as a Ca2+ Receptor 6.7.2 Target Proteins of Ca2+ /Calmodulin 6.7.3 Other Ca2+ Receptors 6.7 Ca2+ as a Signal Molecule Ca2+ is acentral signal molecule of the cell. Following a hormonalor electrical stimulation, an increase in cytosolic Ca2+ occurs, leading to initiation of other reactions in the cell. As outlined above, this increase is limited in time and in space and allows the formation of a variety of differently shaped Ca2+ signals. Examples of Ca2+-dependent reactions are numerous and affect many important processes of the organism, including – muscle contraction – vision process – cell proliferation – secretion – cell motility, formation of the cytoskeleton 6.7 Ca2+ as a Signal Molecule Ca2+ signals in the form of temporally and spatially variable changes in Ca2+ concentration serve as elements of intracellular signal conduction in many signaling pathways. Three main paths for increase in Ca2+ concentration stand out (Table 6.1): – G-protein-mediated signaling pathways – signaling pathways involving receptor tyrosine kinases – influx of Ca2+ via voltage- or ligand-gated Ca2+ channels. Tab. 6.1 Receptors of the plasma membrane that mediate increase of intracellular Ca2+. 6.7 Ca2+ as a Signal Molecule Direct activation of proteins Many proteins have a specific binding site for Ca2+, and their activity is directly dependent on Ca2+ binding. The available Ca2+ concentration thus directly controls the activity of these proteins (see Table 6.2). Tab. 6.2 Ca2+ binding proteins. 6.7 Ca2+ as a Signal Molecule Binding to Ca2+ receptors Another central mechanism of signal transduction via Ca2+ is its binding to Ca2+ -binding proteins also known as Ca2+ receptors. The receptor proteins function as regulatory proteins that couple the Ca2+ signal to other signaling proteins. The Ca2+ receptors are Ca2+ sensors that activate target proteins in response to changes in Ca2+ concentration. Increases in Ca2+ above the concentration of the resting state (ca. 10–7M) lead to specific binding of Ca2+ to Ca2+binding sites on the receptor and concomitant conformational changes that modulate the interaction with downstream target proteins. 6.7.1 Calmodulin as a Ca2+ Receptor The most widespread Ca2+ receptor is calmodulin. Calmodulin is a small protein of ca. 150 amino. The structure of the Ca2+ /calmodulin complex has two globular domains that are separated by a long ahelical section (Fig. 6.13). Both globular domains have two binding sites for Ca2+. Ca2+ is bound via a characteristic helix-loophelix structure, also known as an EF structure. Similar EF structures are found in many, but not all, Ca2+ -binding proteins. Fig. 6.13 Comparison of different Ca2+/Calmodulin structures (from Hoeflich and Ikura, 2002). The figure illustrates the different conformations of calmodulin when bound to target protein kinases. Calmodulin is shown in yellow and calcium ions are depicted in blue. The interaction with the calmodulin binding domain of the protein kinases is mediated by short helices shown in green and blue. CaM-CaMKII: Ca2+/calmodulindependent protein kinase II; CaM-CaMKK: Ca2+/calmodulin-dependent protein kinase kinase; CaM-MLCK: Ca2+/calmodulin-dependent myosin light chain kinase; CaM-EF: Ca2+/calmodulin-dependent edema factor, an adenylyl cyclase, from Bacillus anthracis. 6.7.1 Calmodulin as a Ca2+ Receptor From the structures of the substrates and their complexes with Ca2+ /calmodulin, two main mechanisms of substrate activation have emerged (Fig. 6.14). By one mechanism an autoinhibitory element is displaced from the active site of the target enzyme relieving autoinhibition. Another protein activation mechanism of Ca2+ /calmodulin uses a remodeling of the active site of the target protein. Fig. 6.14 Mechanisms of activation of target proteins by Ca2+/ calmodulin (after Hoeflich and Ikura, 2002). A) Binding of Ca2+/calmodulin relieves autoinhibition (CaMkinases, calcineurin). B) Ca2+/calmodulin remodels the active site inducing an active conformation (anthrax adenylyl cyclase). C) Ca2+/calmodulininduced dimerization of K+-channels. AID: autoinhibition domain. 6.7.2 Target Proteins of Ca2+ /Calmodulin The Ca2+ /calmodulin complex is a signal molecule that is involved in many signal transduction pathways. Ca2+ /calmodulin is involved, e. g., in regulation of proliferation, mitosis, neuronal signal transduction, muscle contraction and glucose metabolism. Different calmodulin subtypes are known which regulate different target proteins. The best characterized target proteins are the calmodulin-dependent adenylyl cyclases, phosphodiesterases, the protein phosphatase calcineurin, protein kinases like the CaM kinases, and the myosin light chain kinase 6.8 Diacylglycerol as a Signal Molecule During cleavage of PtInsP2 by phospholipase C, two signal molecules are formed, InsP2 and diacylglycerol. Whilst InsP2 acts as a diffusible signal molecule in the cytosol after cleavage, the hydrophobic diacylglycerol remains in the membrane. Diacylglycerol can be produced by different pathways, and it has at least two functions (Fig. 6.15). Diacylglycerol is an important source for the release of arachidonic acid, from which biosynthesis of prostaglandins takes place. The glycerine portion of the inositol phosphatide is often esterifed in the 2’ position with arachidonic acid; arachidonic acid is cleaved off by the action of phospholipases of type A2. Fig. 6.15 Formation and function of diacylglycerol. The figure schematically shows two main pathways for formation of diacylglycerol (DAG). DAG can be formed from PtdInsP2 by the action of phospholipase C (PLC). Another pathway starts from phosphatidyl choline. Phospholipase D (PL-D) converts phosphatidyl choline to phosphatidic acid (Ptd), and the action of phosphatases results in DAG. Arachidonic acid, the starting point of biosynthesis of prostaglandins and other intracellular and extracellular messenger substances, can be cleaved from DAG. PKC: protein kinase C; PtdIns: phosphatidyl inositol. 6.9 Other Lipid Messengers Ceramide Ceramide is a lipophilic messenger that regulates diverse signaling pathways involving apoptosis, stress response, cell senescence, and differentiation. For the most part, ceramide’s effects are antagonistic to cell growth and survival. The starting point for the formation of ceramide is sphingomyelin, which occurs especially in the outer layer of the plasma membrane. Ceramide is produced from sphingomyelin by the action of the enzyme sphingomyelinase (Fig. 6.16). Sphingomyelinase has similar cleavage specificity to phospholipase C, in that it cleaves an alcohol-phosphate bond. Activation of sphingomyelinase is observed in response to diverse stress challenges including irradiation, exposure to DNA-damaging agents or treatment with pro-apoptotic ligands like tumor necrosis factor a (TNFα). Because of these properties, ceramide is a potent apoptogenic agent. Fig. 6.16 Formation and function of the messenger substance ceramide. The starting point for the synthesis of ceramide is sphingomyelin, which is converted to phosphocholine and ceramide by the action of a sphingomyelinase. Sphingomyelinase is activated via a pathway starting from tumor necrosis factor α (TNFα) and its receptor. Ceramide serves as an activator of protein kinases and protein phosphatases. R1: fatty acid side chain. 6.10 The NO Signaling Molecule 6.10.1 Reactivity and Stability of NO 6.10.2 Synthesis of NO 6.10.3 Physiological Functions and Attack Points of NO 6.10 The NO Signaling Molecule The biological importance of nitrogen monoxide (NO) as a messenger substance was originally recognized in connection with contraction and relaxation of blood vessels. In the meantime, it has become clear that NO is a universal messenger substance that is found in nearly all living cells. NO takes part in intercellular and intracellular com-munication in higher and lower eucaryotes and it is also found in bacteria and in plant cells. 6.10.1 Reactivity and Stability of NO NO is a radical that is water soluble and can cross membranes fairly freely by diffusion. Because of its radical nature, NO has a lifetime in aqueous solution of only ca. 4 s. Important reaction partners of NO in biological systems are oxygen O2, the O2–radical and transition metals in free or complex form, e. g. Fe2+ in heme. Furthermore, NO readily reacts with nucleophilic centers in peptides and proteins, in particular with the SH groups of Cys residues (Fig. 6.17). Fig. 6.17 Reactions of NO in biological systems. NO reacts in biological systems primarily with O2, with the superoxide anion O2-and with transition metals (Me). The products of the reaction, -NOx, metal -NO adducts (Me-NO) and peroxynitrite (OONO-) react further by nitrosylation of nucleophilic centers. In the cell, these are especially–SH (or thiolate-S-) groups of peptides and proteins (RS-). 6.10.2 Synthesis of NO NO is formed enzymatically from arginine with the help of NO synthase, producing citrulline (Fig. 6.18). Citrulline and arginine are intermediates of the urea cycle, and arginine can be regenerated from citrulline by urea cycle enzymes. Fig. 6.18 Biosynthesis of NO. The starting point of NO synthesis is arginine. Arginine is converted by NO synthase, together with O2 and NADP, to NO and citrulline. Arginine can be regenerated from citrulline via reactions of the urea cycle. 6.10.3 Physiological Functions and Attack Points of NO Toxic Action of NO and Nitrosative Stress When NO is produced in excess amounts and in a less than regulated fashion, nonspecific reactions with various cell constituents including proteins, lipids and DNA are observed. This situation has been termed nitrosative stress in analogy to oxidative stress caused by the generation of reactive oxygen species, ROS. Nitration, nitrosation and oxidation of proteins, lipids and DNA can occur under these conditions and can lead to damage of cellular functions and eventually to cell death. 6.10.3 Physiological Functions and Attack Points of NO Regulatory Function of NO NO produced in a regulated way by enzymatic synthesis is involved in the control of a wide array of cellular functions including relaxation of blood vessels, neurotransmission, cellular immune response and apoptosis. Because of its high reactivity, NO can interact and react with many effector proteins. In Table 6.3, some important bioregulatory proteins are summarized, for which direct modification by NO has been shown. Two target proteins should be mentioned, in particular: Tab. 6.3 Regulatory attack points of NO. Proteins are included for which a direct regulation by NO is assumed (according to Stammler, 1994). Direct evidence of regulatory nitrosylation has only been shown for hemoglobin, however. 6.10.3 Physiological Functions and Attack Points of NO NO-sensitive Guanylyl Cyclase The first cellular target of NO to be identified was a specific isoform of guanylyl cyclase. Stimulation of NO synthase leads to activation of a cytoplasmic NO sensitive guanylyl cyclase. Activation is achieved by binding of NO to a heme group of the enzyme. The associated increase in the cGMP level has multiple consequences. The cGMP can stimulate cGMP-dependent protein kinases; it can also open cGMP controlled ion channels. As a consequence, an increase in the intracellular Ca2+ concentration takes place and a Ca2+ signal is produced. NO can influence both protein phosphorylation and InsP3/diacylglycerol and Ca2+ metabolism by this mechanism and activate a broad palette of biochemical reactions in the cell. 6.10.3 Physiological Functions and Attack Points of NO S-Nitrosylation of Hemoglobin Hemoglobin was the first protein for which a regulatory action of S-nitrosylation was clearly shown (Fig. 6.19). Hemoglobin (Hb) is a tetramer, composed of two α and two β chains. In man, each chain has a heme system, and the β chains have a reactive cysteine group (Cys93). The Hb may bind NO at two sites. Firstly, NO can bind to the Fe(II) of the heme grouping; secondly, NO can accumulate at Cys93 of the β chain by forming an Snitrosyl. Fig. 6.19 Scheme of the function of nitroso-hemoglobin. NO synthase is activated by a stimulatory signal (e. g. a Ca2+ signal) and NO is formed. The NO is transferred by direct or indirect means to hemoglobin in the erythrocytes. NO can bind to hemoglobin as a Fe-NO complex with the heme, and it can exist as a Snitroso derivative of Cys93 of the β subunit (Cys93β). Hemoglobin-bound NO can be transferred to the anion exchange protein AE1, forming SNOAE1. This can transfer NO activity out of the red blood cell and into the vessel wall. In this form, and transferred to low molecular weight SH compounds such as glutathione (GSH) or free cysteine (Cys). The resulting nitrosyl compounds CysSNO and G-SNO can diffuse to target proteins and pass the NO signal on to these. The figure does not show the complex regulation of NO compounds LOGO